Notably, high expression of TLR3 in triple-negative breast cancer indicates a better prognosis (38), and TLR3-activated cDCs produce IFN- λ, which is linked to a good clinical outcome in breast cancer (58). This evidence concerns the gene TLR3 and triple-negative breast carcinoma.